ArticleScientific reports2021

Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study.

Fuman Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.